Skip to search.
 TSX Down 0.79% TSX Ventures Down 0.04%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.30 Down 0.20(40.00%) 4:00PM EST
Prev Close:0.50
Open:0.31
Bid:0.28 x 5000
Ask:0.33 x 2000
1y Target Est:4.28
Beta:0.401161
Next Earnings Date:N/A
Day's Range:0.25 - 0.35
52wk Range:0.25 - 2.94
Volume:18,854,197
Avg Vol (3m):1,971,560
Market Cap:84.54M
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 40.00%84.54M
BMYUp 0.10%101.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.59
Quarterly EPS Est (Dec-15) :-0.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback